Loxo Oncology Inc (LOXO1)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Josh Bilenker
Employees:
29
281 TRESSER BOULEVARD, 9TH FLOOR, STAMFORD, CT 06901
203-653-3880

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Loxo Oncology, Inc. is a biopharmaceutical company, which develops small molecule therapeutics for the treatment of cancer. Its pipeline focuses on cancers that are uniquely dependent on single gene abnormalities, such that a single drug has the potential to treat the cancer with dramatic effect. The company was founded by Joshua H. Bilenker in May 2013 and is headquartered in Stamford, CT.

Data derived from most recent annual or quarterly report
Market Cap 7.184 Billion Shares Outstanding30.615 Million Avg 30-day Volume 766.593 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-1.4
Price to Revenue118.6984 Debt to Equity0.0 EBITDA-152.191 Million
Price to Book Value6.6848 Operating Margin-715.4742 Enterprise Value1.902 Billion
Current Ratio3.529 EPS Growth-0.535 Quick Ratio2.826
1 Yr BETA 1.6301 52-week High/Low 0.0 / Profit Margin-698.9484
Operating Cash Flow Growth309.9906 Altman Z-Score3.472 Free Cash Flow to Firm 129.671 Million
View SEC Filings from LOXO1 instead.

View recent insider trading info

Funds Holding LOXO1 (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding LOXO1

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Events (8k)

  • 8-K: filed on 2019-02-15:
    Item 2.01: Completion of Acquisition or Disposition of Assets
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 5.01: Changes in Control of Registrant
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2019-01-07:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2018-12-06:
    Item 7.01: Regulation FD Disclosure
  • 8-K: filed on 2018-11-27:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2018-11-08:
    Item 2.02: Results of Operations and Financial Condition
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2018-05-08:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2018-03-01:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2018-01-08:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2017-12-27:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2017-12-04:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    MAYLEBEN TIMOTHY M

    • Director
    No longer subject to file 2019-02-15 0

    ELMS STEVE

    • Director
    • 10% Owner
    No longer subject to file 2019-02-15 0

    FUHRMAN ALAN

    • Director
    No longer subject to file 2019-02-15 0

    KUNKEL LORI ANNE

    • Director
    No longer subject to file 2019-02-15 0

    FLAHERTY KEITH T.

    • Director
    No longer subject to file 2019-02-15 0

    NAIDER AVI Z.

    • Director
    No longer subject to file 2019-02-15 0

    BILENKER JOSHUA H. PRESIDENT & CEO

    • Officer
    • Director
    No longer subject to file 2019-02-15 0

    HARR STEVE

    • Director
    No longer subject to file 2019-02-15 0

    BURSTEIN JENNIFER SENIOR VP OF FINANCE

    • Officer
    No longer subject to file 2019-02-15 0

    VAN NAARDEN JACOB CHIEF OPERATING OFFICER

    • Officer
    0 2019-02-15 0

    NANDA NISHA CHIEF DEVELOPMENT OFFICER

    • Officer
    No longer subject to file 2019-02-15 0

    AISLING CAPITAL III LP

    AISLING CAPITAL PARTNERS III LP

    AISLING CAPITAL PARTNERS III LLC

    ELMS STEVE

    SCHIFF ANDREW N

    PURCELL DENNIS J

    • 10% Owner
    No longer subject to file 2018-07-10 0

    ORBIMED ADVISORS LLC

    ORBIMED CAPITAL GP V LLC

    ISALY SAMUEL D

    • Director
    941,000 2017-12-08 0

    BONITA DAVID P

    • Director
    941,000 2017-12-08 0

    BARRETT M JAMES

    • Director
    • 10% Owner
    0 2015-07-28 0

    GOLDSTEIN DOV A MD CFO AND TREASURER

    • Officer
    • 10% Owner
    3,518,366 2015-04-01 0

    LOW JENNIFER A. CHIEF MEDICAL OFFICER

    • Officer
    0 2014-12-19 0

    BARRIS PETER J

    • 10% Owner
    1,789,420 2014-08-06 0

    FLYNN JAMES E

    DEERFIELD MGMT L.P.

    DEERFIELD SPECIAL SITUATIONS FUND, L.P.

    DEERFIELD SPECIAL SITUATIONS INTERNATIONAL MASTER FUND, L.P.

    DEERFIELD MANAGEMENT CO

    DEERFIELD PARTNERS, LP

    DEERFIELD INTERNATIONAL MASTER FUND, L.P.

    • 10% Owner
    • POSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUP
    No longer subject to file 2014-08-06 0

    ARRAY BIOPHARMA INC

    • 10% Owner
    1,609,560 2014-08-06 0

    AISLING CAPITAL III LP

    AISLING CAPITAL PARTNERS III LP

    AISLING CAPITAL PARTNERS III LLC

    ELMS STEVE

    GOLDSTEIN DOV A MD CFO AND TREASURER

    SCHIFF ANDREW N

    PURCELL DENNIS J

    • Officer
    • Director
    • 10% Owner
    3,452,493 2014-08-06 0

    MOTT DAVID M

    • 10% Owner
    1,789,420 2014-08-06 0

    KERINS PATRICK J

    • 10% Owner
    1,789,420 2014-08-06 0

    SANDELL SCOTT D

    • 10% Owner
    1,789,420 2014-08-06 0

    KOLLURI KRISHNA KITTU

    • 10% Owner
    1,789,420 2014-08-06 0

    BASKETT FOREST

    • 10% Owner
    1,789,420 2014-08-06 0

    DRANT RYAN D

    • 10% Owner
    1,789,420 2014-08-06 0

    AI LOXO HOLDINGS LLC

    AI VALUE HOLDINGS, LLC

    ACCESS INDUSTRIES MANAGEMENT, LLC

    BLAVATNIK LEN

    • 10% Owner
    1,368,339 2014-08-06 0

    WELLER HARRY R

    • 10% Owner
    1,789,420 2014-08-06 0

    VISWANATHAN RAVI

    • 10% Owner
    1,789,420 2014-08-06 0

    SONSINI PETER W.

    • 10% Owner
    1,789,420 2014-08-06 0

    FLORENCE ANTHONY A. JR.

    • 10% Owner
    1,789,420 2014-08-06 0

    FLYNN JAMES E

    DEERFIELD MGMT L.P.

    DEERFIELD SPECIAL SITUATIONS INTERNATIONAL MASTER FUND, L.P.

    DEERFIELD SPECIAL SITUATIONS FUND, L.P.

    DEERFIELD MANAGEMENT CO

    • 10% Owner
    • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
    0 2014-07-31 0

    NEW ENTERPRISE ASSOCIATES 14, L.P.

    NEA PARTNERS 14, L.P.

    NEA 14 GP, LTD

    • 10% Owner
    0 2014-07-31 0

    MOYER MIKEL PAUL CHIEF SCIENTIFIC OFFICER

    • Officer
    0 2014-07-31 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    Elevate your investments